AI CEOs Back DNA Rules to Limit AI-Aided Bioweapons Risk
The Spin
Establishment-critical narrative
AI is advancing fast enough that the knowledge barriers keeping bioweapons out of the wrong hands could erode quickly, and mandatory DNA synthesis screening is a straightforward fix. Requiring suppliers to verify buyers and flag dangerous combinations closes a real gap — many companies do this voluntarily, but no law forces them to. When rivals agree on something, that consensus deserves serious attention from Congress.
Pro-establishment narrative
Pushing mandatory DNA screening looks less like a safety policy and more like a power grab by the biggest AI players to lock in compliance costs that crush smaller competitors. Existing safeguards already cover most real risks, and determined bad actors won't be stopped by paperwork requirements. Handing regulatory leverage to the very companies lobbying for it is a recipe for stifled innovation and a less competitive biotech market.
